Many service providers have settled near the research institutions and biotech companies on Campus Berlin-Buch.
ImaGenes GmbH, now part of the British Source BioScience plc, is one of the most advanced service centers for genome research and medical diagnostics in Europe and has one of the largest clone collections in the world.
In the Incubation Center of Campus Berlin-Buch BIOSYNTAN GmbH produces 1,500 custom-designed peptides a year in state-of-the-art laboratories. Peptides and special bioorganic substances are synthesized in high purity on the scale of 1 to 500 mg. Besides standard syntheses, special syntheses are performed of specific peptides, e.g. peptides with fluorescence markers and hapten modifications. The company emp Biotech GmbH produces biologically active molecules and specialty and fine chemicals, among others chromatographic materials in extremely high quality.
Lipidomix GmbH is a specialized lipid analysis lab on campus, which conducts high-throughput lipidomic analysis, in particular eicosanoids. It is based on rapid-resolution-HPLC in combination with triplequad tandem mass spectrometry. Lipidomix develops and validates analysis methods for areas in the life sciences, food monitoring, forensics and others.
Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin
2021-04-14 / Eckert & Ziegler is proud to announce that it is expanding its production site in Berlin, Germany, with a new production facility for the contract manufacturing of radiopharmaceuticals.more ...
Eckert & Ziegler Receives Technetium Generator Licenses for Brazil
The Brazilian regulator ANVISA has provided Eckert & Ziegler Brasil Comercial Ltda., a fully owned subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), with a li...more ...
Eckert & Ziegler: Dividend Proposal EUR 0.45 per Share. Profit Increase in 2020. Positive Outlook for 2021.
Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) achieved sales of EUR 176.1 million (previous year EUR 178.5 million) and a net profit of EUR 22.9 million (previous year EUR 22.0 million) in the 2020 ...more ...
Epigenetik und die große Frage: Beeinflusst die Umwelt unser Erbgut?
Die Epigenetik bietet konzeptionell neue Ansätze für das Verständnis genetischer Regulation von Entwicklungs- und Erkrankungs-Prozessen.more ...
GMP Biotech Summer School
Good Manufacturing Practice (GMP) Basic Course Biotechnology (English)more ...
Pharmacokinetics - Essentials for Project Managers in Biotech Companies
Basics in understanding pharmacokinetics in clinicial development - for non-physiciansmore ...